| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $18.1M-9.9% | $20.1M-0.3% | $20.2M+10.1% | $18.4M+153.2% | $7.2M |
| Cost of goods sold | $13.6M-12.2% | $15.5M+3.8% | $14.9M+7.2% | $13.9M+149.9% | $5.6M |
| Gross profit | $4.6M-2.3% | $4.7M-11.8% | $5.3M+19.0% | $4.5M+164.1% | $1.7M |
| Research and development | $203K-26.7% | $277K+6.1% | $261K+9.7% | $238K+56.6% | $152K |
| Selling and marketing | $1.9M-22.2% | $2.4M-8.2% | $2.6M+10.1% | $2.4M+63.9% | $1.5M |
| General and administrative | $3.6M+0.8% | $3.5M-19.2% | $4.4M+22.2% | $3.6M+119.3% | $1.6M |
| Total operating expenses | $5.7M-9.3% | $6.2M-14.3% | $7.3M+17.1% | $6.2M+91.5% | $3.3M |
| Operating (loss) | -$1.1M+30.3% | -$1.6M+21.2% | -$2.0M-12.1% | -$1.8M-12.9% | -$1.6M |
| Unrealized gain on marketable securities | $0 | $0 | — | — | — |
| Interest and other income, net | $138K-25.4% | $185K+33.1% | $139K | — | — |
| Total other income | $138K-25.4% | $185K+4.5% | $177K+142.4% | -$417K+54.5% | -$916K |
| Net (loss) | -$948K+30.9% | -$1.4M | — | — | — |
| Weighted average shares outstanding: basic and diluted (Note 4) (in shares) | 9.91B-5.5% | 10.48B-4.0% | 10.92B+3.3% | 10.58B+87.4% | 5.65B |
| Net (loss) income per common share basic and diluted (in dollars per share) | -$0.10+23.1% | -$0.13+18.8% | -$0.16-23.1% | -$0.13-18.2% | -$0.11 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.